REGN-7257
- Generic Name
- REGN-7257
REGN7257 in Adult Patients With Severe Aplastic Anemia That Is Refractory to or Relapsed on Immunosuppressive Therapy
- First Posted Date
- 2020-06-01
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Regeneron Pharmaceuticals
- Target Recruit Count
- 33
- Registration Number
- NCT04409080
- Locations
- 🇺🇸
Cleveland Clinic Foundation, Cleveland, Ohio, United States
🇺🇸The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
🇫🇷Hopital Saint-Louis - APHP, Paris, Ile-de-France, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath